These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 32848616)

  • 1. Substantia Nigra Hyperechogenicity Reflects the Progression of Dopaminergic Neurodegeneration in 6-OHDA Rat Model of Parkinson's Disease.
    Zhang S; Tao K; Wang J; Duan Y; Wang B; Liu X
    Front Cell Neurosci; 2020; 14():216. PubMed ID: 32848616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Iron accumulation and microglia activation contribute to substantia nigra hyperechogenicity in the 6-OHDA-induced rat model of Parkinson's disease.
    Zhu Y; Wang B; Tao K; Yang H; Wang Y; Zhou T; Yang Y; Yuan L; Liu X; Duan Y
    Parkinsonism Relat Disord; 2017 Mar; 36():76-82. PubMed ID: 28108264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Features in Parkinson's Disease Patients with Hyperechogenicity in Substantia Nigra: A Cross-Sectional Study.
    Zhu S; Wang Y; Jiang Y; Gu R; Zhong M; Jiang X; Shen B; Zhu J; Yan J; Pan Y; Zhang L
    Neuropsychiatr Dis Treat; 2022; 18():1593-1601. PubMed ID: 35942277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A nomogram based on neuron-specific enolase and substantia nigra hyperechogenicity for identifying cognitive impairment in Parkinson's disease.
    Hou C; Yang F; Li S; Ma HY; Li FX; Zhang W; He W
    Quant Imaging Med Surg; 2024 May; 14(5):3581-3592. PubMed ID: 38720848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Substantia Nigra Echogenicity Signal Correlated with Clinical Features in Patients with Parkinson's Disease in Xinjiang.
    Wei R; Zhang Y; Li P; Xu Z; Zhang L; He Y; Wu Q; Shi Y; Yuan Y; Aisha A
    Parkinsons Dis; 2023; 2023():8867546. PubMed ID: 37304832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Parkinson's disease-like midbrain sonography abnormalities are frequent in depressive disorders.
    Walter U; Hoeppner J; Prudente-Morrissey L; Horowski S; Herpertz SC; Benecke R
    Brain; 2007 Jul; 130(Pt 7):1799-807. PubMed ID: 17329323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroimaging Correlates of Substantia Nigra Hyperechogenicity in Parkinson's Disease.
    Prasuhn J; Strautz R; Lemmer F; Dreischmeier S; Kasten M; Hanssen H; Heldmann M; Brüggemann N
    J Parkinsons Dis; 2022; 12(4):1191-1200. PubMed ID: 35180131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Substantia nigra hyperechogenicity in depressive subjects relates to motor asymmetry and impaired word fluency.
    Hoeppner J; Prudente-Morrissey L; Herpertz SC; Benecke R; Walter U
    Eur Arch Psychiatry Clin Neurosci; 2009 Mar; 259(2):92-7. PubMed ID: 18806917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Substantia nigra hyperechogenicity in essential tremor and Parkinson's disease: a longitudinal study.
    Cardaioli G; Ripandelli F; Paolini Paoletti F; Nigro P; Simoni S; Brahimi E; Romoli M; Filidei M; Eusebi P; Calabresi P; Tambasco N
    Eur J Neurol; 2019 Nov; 26(11):1370-1376. PubMed ID: 31094036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Substantia nigra hyperechogenicity in Polish patients with Parkinson's disease.
    Ambrosius W; Michalak S; Owecki M; Łukasik M; Florczak-Wyspiańska J; Kozubski W
    Folia Morphol (Warsz); 2014 Aug; 73(3):267-71. PubMed ID: 25706660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human neuromelanin induces neuroinflammation and neurodegeneration in the rat substantia nigra: implications for Parkinson's disease.
    Zecca L; Wilms H; Geick S; Claasen JH; Brandenburg LO; Holzknecht C; Panizza ML; Zucca FA; Deuschl G; Sievers J; Lucius R
    Acta Neuropathol; 2008 Jul; 116(1):47-55. PubMed ID: 18343932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Transcranial parenchymal sonography in the diagnosis of Parkinson's disease].
    Mijajlović M; Petrović I; Stojković T; Svetel M; Stefanova E; Kostić VS
    Vojnosanit Pregl; 2008 Aug; 65(8):601-5. PubMed ID: 18751340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application and progress of transcranial substantial ultrasound in Parkinson's disease.
    Ma X; Li T; Du L; Han T
    Front Neurol; 2022; 13():1091895. PubMed ID: 36530621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Transcranial sonography of substantia nigra in patients with Parkinson's disease].
    Miwa H
    Rinsho Shinkeigaku; 2013; 53(11):981-2. PubMed ID: 24291852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Substantia nigra hyperechogenicity does not correlate with motor features in Parkinson's disease.
    Jesus-Ribeiro J; Sargento-Freitas J; Sousa M; Silva F; Freire A; Januário C
    J Neurol Sci; 2016 May; 364():9-11. PubMed ID: 27084206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcranial brain sonography for Parkinsonian syndromes.
    Bor-Seng-Shu E; Paschoal FM; Almeida KJ; De Lima Oliveira M; Nogueira RC; Teixeira MJ; Walter U
    J Neurosurg Sci; 2019 Aug; 63(4):441-449. PubMed ID: 31210040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cognitive Performance Patterns in Healthy Individuals with Substantia Nigra Hyperechogenicity and Early Parkinson's Disease.
    Yilmaz R; Gräber S; Roeben B; Suenkel U; von Thaler AK; Heinzel S; Metzger FG; Eschweiler GW; Maetzler W; Berg D; Liepelt-Scarfone I
    Front Aging Neurosci; 2016; 8():271. PubMed ID: 27895578
    [No Abstract]   [Full Text] [Related]  

  • 18. The role of substantia nigra sonography in the differentiation of Parkinson's disease and multiple system atrophy.
    Zhou HY; Huang P; Sun Q; Du JJ; Cui SS; Hu YY; Zhan WW; Wang Y; Xiao Q; Liu J; Tan YY; Chen SD
    Transl Neurodegener; 2018; 7():15. PubMed ID: 30062008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic value of combined assessment of olfaction and sustantia nigra hyperechogenicity for Parkinson's disease.
    López Hernández N; García Escrivá A; Shalabi Benavent M
    Neurologia; 2015 Oct; 30(8):496-501. PubMed ID: 24839905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcranial sonography image characteristics in different Parkinson's disease subtypes.
    Sheng AY; Zhang YC; Sheng YJ; Wang CS; Zhang Y; Hu H; Luo WF; LIu CF
    Neurol Sci; 2017 Oct; 38(10):1805-1810. PubMed ID: 28726052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.